AlloVir (ALVR) News Today $0.57 +0.01 (+1.79%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period AlloVir, Inc. (NASDAQ:ALVR) Sees Significant Drop in Short InterestAlloVir, Inc. (NASDAQ:ALVR - Get Free Report) saw a large drop in short interest in October. As of October 31st, there was short interest totalling 3,950,000 shares, a drop of 19.2% from the October 15th total of 4,890,000 shares. Based on an average trading volume of 256,400 shares, the days-to-cover ratio is currently 15.4 days.November 15, 2024 | marketbeat.com$hareholder Alert: The M&A Class Action Firm Continues to Investigate the Merger of ROIC, VINE, ALVR and CDMONovember 13, 2024 | stockhouse.comALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc. - ALVRNovember 9, 2024 | businesswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMKR and ALVR on Behalf of ShareholdersNovember 9, 2024 | globenewswire.comAlloVir (NASDAQ:ALVR) Stock, Option ChainNovember 9, 2024 | benzinga.comAlloVir and Kalaris Merge to Advance Retinal TherapiesNovember 9, 2024 | markets.businessinsider.comAlloVir falls after all-stock merger deal with KalarisNovember 9, 2024 | msn.comAlloVir to combine with Kalaris Therapeutics in all-stock transactionNovember 9, 2024 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMKR and ALVR on Behalf of ShareholdersNovember 8, 2024 | prnewswire.comSTOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of AlloVir, Inc. – ALVRNovember 8, 2024 | globenewswire.comALVR Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of AlloVir, Inc. Is Fair to ShareholdersNovember 8, 2024 | businesswire.comShareholder Alert: Ademi LLP Investigates Whether AlloVir, Inc. Is Obtaining a Fair Price for Its Public ShareholdersNovember 8, 2024 | businesswire.comAlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the RetinaNovember 8, 2024 | globenewswire.comDiscovering Opportunities: AlloVir And 2 Other US Penny StocksOctober 31, 2024 | finance.yahoo.comWasatch Small Cap Growth InstitutionalOctober 16, 2024 | morningstar.comOctagon Capital Advisors LP Increases Stake in AlloVir IncOctober 12, 2024 | finance.yahoo.comWasatch Small Cap Growth InvestorSeptember 28, 2024 | morningstar.comAlloVir (NASDAQ:ALVR) Shares Up 1%AlloVir (NASDAQ:ALVR) Stock Price Up 1%September 17, 2024 | marketbeat.comKuehn Law Encourages Investors of AlloVir, Inc. to Contact Law FirmSeptember 16, 2024 | globenewswire.comMaintaining Hold on AlloVir Amid Financial Performance and Strategic UncertaintyAugust 14, 2024 | markets.businessinsider.comAlloVir (NASDAQ:ALVR) Stock Quotes, Forecast and News SummaryAugust 8, 2024 | benzinga.comHere's Why AlloVir (NASDAQ:ALVR) Must Use Its Cash WiselyJuly 31, 2024 | finance.yahoo.comAcadian Asset Management LLC Has $1.20 Million Stake in AlloVir, Inc. (NASDAQ:ALVR)Acadian Asset Management LLC raised its stake in shares of AlloVir, Inc. (NASDAQ:ALVR - Free Report) by 694.6% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 1,587,451 shares of the company's stock after purchasing an additional 1,387,666 shares during thJuly 26, 2024 | marketbeat.comAlloVir (NASDAQ:ALVR) Trading Up 3.3%AlloVir (NASDAQ:ALVR) Shares Up 3.3%July 9, 2024 | marketbeat.comAlloVir, Inc. (NASDAQ:ALVR) Shares Sold by Wasatch Advisors LPWasatch Advisors LP reduced its position in AlloVir, Inc. (NASDAQ:ALVR - Free Report) by 40.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,784,623 shares of the company's stock after selling 2,535,248June 12, 2024 | marketbeat.comQ2 2024 EPS Estimates for AlloVir, Inc. (NASDAQ:ALVR) Cut by AnalystAlloVir, Inc. (NASDAQ:ALVR - Free Report) - Analysts at Leerink Partnrs dropped their Q2 2024 EPS estimates for AlloVir in a report issued on Monday, May 13th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will post earnings per share of ($0.04) for the quarter, down from theMay 16, 2024 | marketbeat.comALVR Stock Earnings: AlloVir Misses EPS for Q1 2024May 14, 2024 | investorplace.comAlloVir, Inc. (ALVR)May 1, 2024 | finance.yahoo.comShort Interest in AlloVir, Inc. (NASDAQ:ALVR) Rises By 5.7%AlloVir, Inc. (NASDAQ:ALVR - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 6,270,000 shares, a growth of 5.7% from the February 29th total of 5,930,000 shares. Based on an average trading volume of 1,970,000 shares, the short-interest ratio is currently 3.2 days.April 2, 2024 | marketbeat.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlloVirMarch 21, 2024 | stockhouse.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVRMarch 19, 2024 | prnewswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlloVirMarch 19, 2024 | stockhouse.comALVR Stock Earnings: AlloVir Misses EPS for Q4 2023March 18, 2024 | investorplace.comALVR DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities ...March 17, 2024 | businesswire.comALVR DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALVRMarch 17, 2024 | businesswire.com4-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the FirmMarch 15, 2024 | stockhouse.comALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMarch 15, 2024 | prnewswire.comClass Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmMarch 14, 2024 | prnewswire.com5-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the FirmMarch 14, 2024 | stockhouse.comALVR IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVRMarch 12, 2024 | prnewswire.comAlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVRMarch 12, 2024 | prnewswire.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlloVirMarch 11, 2024 | markets.businessinsider.comAlloVir, Inc. (NASDAQ:ALVR) Receives Average Rating of "Reduce" from AnalystsAlloVir, Inc. (NASDAQ:ALVR - Get Free Report) has been given an average rating of "Reduce" by the six brokerages that are currently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, three have given a hold recommendation and one has assMarch 11, 2024 | marketbeat.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlloVirMarch 9, 2024 | markets.businessinsider.comALLOVIR INVESTOR ALERT: Kirby McInerney LLP Alerts AlloVir, Inc. (ALVR) Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitMarch 8, 2024 | markets.businessinsider.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVRMarch 7, 2024 | prnewswire.comLost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyMarch 6, 2024 | prnewswire.comROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVRMarch 5, 2024 | prnewswire.comAlloVir (ALVR) Scheduled to Post Quarterly Earnings on MondayAlloVir (NASDAQ:ALVR) will be releasing earnings on Monday, March 4, Yahoo Finance reports.March 3, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVRMarch 3, 2024 | prnewswire.com Get AlloVir News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVR and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. ALVR Media Mentions By Week ALVR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALVR News Sentiment▼2.090.45▲Average Medical News Sentiment ALVR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALVR Articles This Week▼52▲ALVR Articles Average Week Get AlloVir News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ATRA News BLUE News FATE News ATYR News BNTC News ACB News BMEA News PYXS News ZNTL News CYBN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALVR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AlloVir, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AlloVir With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
